Search Results 71-80 of 16250 for actinic keratosis clinical trials
This phase III trial compares memantine to usual treatment in treating patients with brain tumors that are newly diagnosed or has come back (recurrent).
CAR-T cell therapy is a breakthrough immunotherapy for a growing number of indications. Learn how Mayo Clinic physician Saad J. Kenderian, M.B., Ch.B., ...
Immunotherapy is a treatment with medicine that helps the body's immune system kill cancer ... Clinical trials. Explore Mayo Clinic studies ... Actinic keratosis, ...
The purpose of this study is to evaluate the safety and tolerability of multiple subcutaneous injections of a mutanome-directed active immunotherapy (TG4050) in ...
The purpose of this study is to compare radiation dermatitis severity in irradiated skin protected by an agent versus uncovered skin (internal control) based on ...
These clinical trials are the culmination of nearly four years of research under an SU2C Melanoma Dream Team grant. Metastatic melanoma is a type of cancer that ...
To prospectively collect blood and tumor tissue from esophageal cancer patients to identify specific esophageal cancer mutations that can be measured in the ...
Methyl aminolevulinate is used with photodynamic therapy (light treatment) to treat actinic keratosis (AK) on the face and scalp. Actinic keratoses are skin ...
The purpose of this research trail is to study the genetic alteration/mutation and immune profiling in surgical resected Non-small Cell Lung Cancer (NSCLC) ...
Open-label study using ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy in patients with recurrent or metastatic head and neck and squamous cell ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.